Trade now with Barclays Stockbrokers
| EPIC | OXB |
| Sector | Pharma and Biotech |
| ISIN | GB00BDFBVT43 |
| Market Sector | MAIN |
| Market Segment | SSMM |
| Main Indices | techMARK, FTSE 250, FTSE 350, FTSE All-Share, FTSE techMARK Focus |
| Country of register | Great Britain |
| Currency | British Pound |
| Market Cap | £1,085.57m |
| NMS | 2,000 |
| Shares in issue | 120.75m |
| Date Listed | 17-Apr-2001 |
| Currency | UK Pounds |
| Share Price | 899.00p |
| Change Today | 95.00p |
| % Change | 11.82 % |
| 52 Week High | 910.78 |
| 52 Week Low | 232.50 |
| Volume | 1,165,739 |
| Shares Issued | 120.75m |
| Market Cap | £1,085.57m |
| Beta | 1.74 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:23 | 776 @ 896.12p |
| 12:21 | 222 @ 899.00p |
| 12:21 | 161 @ 899.00p |
| 12:21 | 42 @ 899.00p |
| 12:21 | 313 @ 899.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research